Tyler Jacks

David H Koch Professor
Department
David H Koch Institute for Integrative Cancer Res
Technology Areas
Therapeutics: Small Molecules, Proteins & Antibodies, Nucleic Acids, Vaccines / Biotechnology: Biomedical Devices & Systems, DNA & RNA Editing / Diagnostics: Assays / Chemicals & Materials: Nanotechnology & Nanomaterials / Drug Discovery and Research Tools: Antibodies / Drug Delivery: Vectors & Virus like Particles
Impact Areas
Healthy Living, Uncharted Frontiers

Technologies

CD80 is a Biomarker of p53 Activity and a Target for Cancer Therapy

Technology / Case number: #15386H
David Feldser / Leah Schmidt / Tyler Jacks
Technology Areas: Diagnostics / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Method for High Efficiency in Vivo Gene Editing

Technology / Case number: #17117H
Wen Xue / Joseph Dorkin / Hao Yin / Tyler Jacks / Daniel Anderson
Technology Areas: Biotechnology / Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

Augmentation of T and B Cell Activation with a Novel Cysteine Protease Linker Sequence

Technology / Case number: #25338
Sean-Luc Shanahan / Tyler Jacks
Technology Areas: Chemicals & Materials / Therapeutics
Impact Areas: Healthy Living
License

Targeting Lung Microbiota and its Responding Immune Pathways for Lung Cancer Treatment

Technology / Case number: #20602HRJ
Paul Blainey / Chengcheng Jin / Georgia Lagoudas / Tyler Jacks
Technology Areas: Diagnostics / Therapeutics
Impact Areas: Healthy Living
License

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

Sign Up